Cargando…
Integrated MRSA-Management (IMM) with prolonged decolonization treatment after hospital discharge is effective: a single centre, non-randomised open-label trial
BACKGROUND: Guidelines for the control of hospital-acquired MRSA include decolonization measures to end MRSA carrier status in colonized and infected patients. Successful decolonization typically requires up to 22 days of treatment, which is longer than the average hospital length of stay (LOS). Inc...
Autores principales: | Jahn, Bernhard, Wassenaar, Trudy M., Stroh, Annemarie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908775/ https://www.ncbi.nlm.nih.gov/pubmed/27307987 http://dx.doi.org/10.1186/s13756-016-0124-5 |
Ejemplares similares
-
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016) -
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016) -
MRSA decolonization failure—are biofilms the missing link?
por: Günther, Frank, et al.
Publicado: (2017) -
562. Reducing MRSA Bacteremia in Adult Patients through MRSA Decolonization Bundle
por: Goldman, Erin, et al.
Publicado: (2019) -
Success rates of MRSA decolonization and factors associated with failure
por: Yiek, Wing-Kee, et al.
Publicado: (2022)